The Human Milk Oligosaccharides (HMO) Market study works as a boon for all business owners trying to identify the exact size of the target audience in a specific geographic location. Human Milk Oligosaccharides (HMO) Market enables entrepreneurs to determine the regional market for their business expansion.

New York, NY -- (SBWire) -- 04/29/2019 --The growth of the dairy industry is a significant factor estimated to drive market growth.

Market Size – USD 18.57 billion in 2018, Market Growth - CAGR of 20.9%, Market Trends – Growing demand for infant formulation

The global Human Milk Oligosaccharides (HMO) market is expected to reach USD 87.03 Billion by 2026, according to a new report by Reports and Data. HMOs (Human Milk Oligosaccharides) are sugars present in human breast milk and are the third-most-abundant solid component (after lactose and fats). It promotes vital health benefits associated with immunity, digestion, and cognitive health.

Key participants include Inbiose NV, Glycom A/S, Elicityl SA, Medolac Laboratories, Jennewein Biotechnologie GmbH, ZuChem Inc., Glycosyn LLC, Dextra Laboratories, DuPont (Health & Nutrition), and FrieslandCampina among others.

Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/1303

Growth in consumer awareness pertaining to infant health is anticipated to be the most significant factor in stimulating the market demand. Furthermore, huge investments by leading market players in emerging markets are estimated to drive market growth.

A surge in the number of middle-class households coupled with an increase in the number of working women is among the main reasons supporting the growth of the infant formula market. Presence of several companies and resultant competition in this market is expected to assist the application of HMO in infant formula during the forecast period, which in turn would drive the market growth. Besides, high demand for dietary supplements attributing to increased health consciousness is forecasted to boost the market demand in the future. HMOs in dietary supplements offer health benefits, like enhanced immune system and digestive comfort. According to the WHO, the total world population is estimated reach 9.5 billion by 2050. This rise in population will play an instrumental role in the growth of the market.

Limited availability of raw materials coupled with high cost of chemical and enzymatic synthesis techniques and a shortage of technical expertise are some of the factors that may create hindrances to the growth of the market.

Further key findings from the report suggest
- The fucosyllactose contributed to the largest market share of approximately 50% in 2018 followed by the sialyllactose with a market share of approximately 30%. 2?-FL is the most abundant oligosaccharide in human milk, making up around 20% to 30% of all oligosaccharides in human milk. 2?-FL is considered to play a crucial role in protecting and promoting the health of newborn infants. More than 130 different oligosaccharides have been identified in human breast milk, with 2'-FL being the most abundant.
- The infant formula dominated the market with a market share of approximately 80% in 2018 and is projected to witness a growth rate of 20.9% in the forecast period. Rising concerns pertaining to infant health and safety are the major factors estimated to propel market growth in the period 2019-2026. HMOs, play a crucial role in the overall development of infants. These oligosaccharides are responsible for the development of healthy gut, brain, and immune system. Functional food and beverages are projected to experience substantial growth in the upcoming years.
- North America held the largest market share during the forecast period and is forecasted to have an annual growth rate of 20.9%. Major market players, such as Inbiose NV, Glycom A/S, and Elicityl S.A., are emphasizing on R&D for the development of advanced technologies for commercial-scale HMO production.
- North America experiences a high demand for donor human milk. Nevertheless, there are only 11 milk banks in the U.S. and Canada, which are not enough to cater to the rising demand for donor milk. This factor is expected to drive the usage of HMO in infant formula to provide proper nutrition to the infants.

Order Now: https://www.reportsanddata.com/checkout-form/1303

Segments covered in the report:
For the purpose of this report, Reports and Data have segmented global Human Milk Oligosaccharides (HMO) market on the basis of product, type, applications, and region:

Product Outlook (Volume, Kilo Tons; 2016-2026 and Revenue, USD Million; 2016-2026)
- Multijet Printing (MJP)
- Direct Metal Laser Sintering (DMLS)
- Fused Deposition Modelling (FDM)
- Stereolithography (SLA)
- Selective Laser Melting (SLM)
- Electronic Beam Melting (EBM)
- Laser Metal Deposition (LMD)
- Selective Laser Sintering (SLS)
- Laminated Object Manufacturing (LOM)
- Others

Type Outlook (Volume, Kilo Tons; 2016-2026 and Revenue, USD Million; 2016-2026)
- Metal
- Polymers
- Ceramics
- Others

Applications Outlook (Volume, Kilo Tons; 2016-2026 and Revenue, USD Million; 2016-2026)
- Prototyping
- Tooling
- R&D & Innovation
- Manufacturing Complex Parts
- Others

Regional Outlook (Volume, Kilo Tons; 2016-2026 and Revenue, USD Million; 2016-2026)
- North America
o U.S.
- Europe
o France
o UK
- Asia Pacific
o China
o India
o Japan
- Latin America
o Brazil
- MEA

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/human-milk-oligosaccharides-hmo-market

About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:
John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-800-819-3052
E-mail: sales@reportsanddata.com